Knoa Pharma: Pain trials
The registry lists 13 Pain studies with Knoa Pharma as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 1 1Phase 2 5Phase 3 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Analgesic Efficacy and Safety of V120083 in Subjects With Osteoarthritis (OA) of the KneeCompletedNCT03028870Phase 2Results posted
- Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back PainCompletedNCT01452529Phase 3Results posted
- Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.CompletedNCT01400139Phase 3Results posted
- Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001CompletedNCT01369615Phase 3Results posted
- Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in ChildrenCompletedNCT01324570Phase 3Results posted
- Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring OpioidsCompletedNCT01192295Phase 3Results posted
- Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension StudyCompletedNCT01151098Phase 3Results posted
- A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the KneeTerminatedNCT02847702Phase 2
- Experimental Biomarker Study for Pain ThresholdsCompletedNCT02695745Phase 1
- Safety, Pharmacokinetics (PK), and Effectiveness of Hydrocodone Bitartrate (HYD) Extended-Release Tablets in ChildrenWithdrawnNCT02542098Phase 2
- Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)CompletedNCT01688947Phase 2
- Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the KneeCompletedNCT01688934Phase 2
- Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent PainTerminatedNCT00365898Phase 3